The LaBeaud lab is an infectious disease research lab at Stanford University School of Medicine. Our area of research is arboviral epidemiology, the study of arthropod- (or mosquito-) borne viruses. In particular, Dr. LaBeaud investigates dengue fever, chikungunya, Zika virus, and Rift Valley fever virus in Kenya and other developing regions. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections.
LaBeaud Lab Values and Guiding Principles
We believe in better health for all children in the world and in health equity for all. We believe that all people should have the right to be informed and educated about their risk for disease, and empowered to minimize those risks and to be diagnosed and treated effectively. Furthermore, we firmly believe in innovation, excellence, and advancement in science, in establishing meaningful collaborations with the communities we impact, and to give back to those communities to the extent of our abilities. Finally, we believe in inspirational training of young investigators and eager learners of all backgrounds and ages both locally and abroad to ensure our work continues for generations to come. And all the other good stuff…
We approach our research activities with passion and humility. Our work centers on long term relationships with collaborators and communities in our sites so that we can bring better diagnostics, technologies, care and treatment to all people regardless of wealth. We partner with the best scientists in our field to bring innovative solutions to complex global health problems. We embrace challenges, critically evaluate our approaches, and embrace uncertainty at all steps. And all that other superhero stuff…
In the next three years, we will:
1) Share our knowledge about arboviral diseases with the world in a highly visible peer reviewed journal;
2) Improve diagnoses and health outcomes of residents in our research sites;
3) Conduct solutions based research on under-measured determinants of disease;
4) Decrease disease risk through community-based interventions;
5) Empower our communities to make informed health decisions by more direct communication; and
6) Partner with policy makers, community stakeholders and the media to direct change.